Susan Bailey, MD
Vascular Surgery · San Francisco, CANPI 1487742425
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,137 of the $2,831 with a category attached, or 75.5%. 27 manufacturers reported payments, led by Medtronic at 32.7% of the total. Reporting peaked in 2019 at $1,247 and has fallen 82.4% since, to $220 in 2025. That places this record below the midpoint for vascular surgery clinicians in CA, where the typical reported total is $3,945.
Across 106 payments — averaging $26.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$926
- Amgen$319
- Novo Nordisk$289
- Johnson & Johnson$173
- Lilly USA, LLC$165
- Merck$121
- plus $838 from 21 others
What the payments were for
- Travel & lodging$69324%
- Food & beverage$2,13776%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 14 | $926 |
| Amgen | 12 | $319 |
| Novo Nordisk | 15 | $289 |
| Johnson & Johnson | 8 | $173 |
| Lilly USA, LLC | 9 | $165 |
| Merck | 6 | $121 |
| Pfizer | 4 | $91 |
| E.r. Squibb & Sons, L.L.C. | 5 | $83 |
| AbbVie | 3 | $77 |
| AstraZeneca | 4 | $73 |
| GSK | 3 | $59 |
| Boehringer Ingelheim | 3 | $58 |
| Smith+Nephew | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $41 |
| Eisai Inc. | 2 | $38 |
| Astellas Pharma US Inc | 1 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Boston Scientific | 1 | $23 |
| Radius Health, Inc. | 1 | $22 |
| Viiv Healthcare Company | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Exact Sciences | 1 | $19 |
| RGH Enterprises LLC | 1 | $16 |
| Acell, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HawkOne$593
How this compares
$2,831 in reported general payments places this provider in the 45th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular surgery in San Francisco
- John LongSan Francisco$51K
- Son DuongFountain Valley$503K
- Venita ChandraPalo Alto$488K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
- Johnathon RolloLos Angeles$337K
- Melissa LojaFairfield$272K
- Jason LeePalo Alto$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.